Trifork Group AG
5/2025・Trifork Group AG – Reporting of transactions made by persons discharging managerial responsibilities
5/2025・Trifork Group AG – Reporting of transactions made by persons discharging managerial responsibilities
Company announcement no. 5 / 2025
Schindellegi, Switzerland – 26 February 2025
Reporting of transactions made by persons discharging managerial responsibilities
Pursuant to the Market Abuse Regulation Article 19, Trifork Group AG (Swiss company registration number CHE-474.101.854) (“Trifork”) hereby notifies receipt of information of the following transactions made by persons discharging managerial responsibilities in Trifork in connection with fixed salaries paid in shares. Reference is made to company announcement no. 1/2025 on 21 January 2025.
1. | Details of the person discharging managerial responsibilities/person closely associated | ||
a) | Name | Jørn Larsen | |
2. | Reason for the notification | ||
a) | Position/status | CEO | |
b) | Initial notification/ Amendment | Initial notification | |
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Trifork Group AG | |
b) | LEI | 8945004BYZKXPESTBL36 | |
4.1 | Details of the transaction(s) | ||
a) | Description of the financial instrument, type of instrument Identification code | Shares ISIN CH1111227810 | |
b) | Nature of the transaction | A share of 25% of the fixed monthly salary is paid out in shares as described in the company announcement no. 1/2025. | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
DKK 0 | 1’345 | ||
d) | Aggregated information — Aggregated volume — Price | N/A | |
e) | Date of the transaction | 26 February 2025 | |
f) | Place of the transaction | Outside a trading venue |
1. | Details of the person discharging managerial responsibilities/person closely associated | ||
a) | Name | Kristian Wulf-Andersen | |
2. | Reason for the notification | ||
a) | Position/status | CFO | |
b) | Initial notification/ Amendment | Initial notification | |
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Trifork Group AG | |
b) | LEI | 8945004BYZKXPESTBL36 | |
4.1 | Details of the transaction(s) | ||
a) | Description of the financial instrument, type of instrument Identification code | Shares ISIN CH1111227810 | |
b) | Nature of the transaction | A share of 10% of the fixed monthly salary is paid out in shares as described in the company announcement no. 1/2025. | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
DKK 0 | 358 | ||
d) | Aggregated information — Aggregated volume — Price | N/A | |
e) | Date of the transaction | 26 February 2025 | |
f) | Place of the transaction | Outside a trading venue |
Information and questions
Frederik Svanholm, Group Investment Director, frsv@trifork.com, +41 79 357 73 17
About Trifork
Trifork is a pioneering global technology partner, empowering enterprise and public sector customers with innovative solutions. With 1,278 professionals across 76 business units in 15 countries, Trifork delivers expertise in inspiring, building, and running advanced software solutions across diverse sectors, including public administration, healthcare, manufacturing, logistics, energy, financial services, retail, and real estate. Trifork Labs, the Group’s R&D hub, drives innovation by investing in and developing synergistic and high-potential technology companies. Trifork Group AG is a publicly listed company on Nasdaq Copenhagen. Learn more at trifork.com.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Magna International Inc.14.5.2025 23:00:00 CEST | Press release
Magna Announces Senior Notes Offerings
WillScot14.5.2025 22:05:00 CEST | Press release
WillScot Announces Investor Conference Schedule for June 2025
Galapagos NV14.5.2025 22:01:00 CEST | Press release
Galapagos Announces Oral Presentations at EHA and ICML 2025 Featuring Promising New Data from ATALANTA-1 study of Investigational CAR-T Candidate GLPG5101
F. Hoffmann-La Roche Ltd14.5.2025 22:00:00 CEST | Press release
Roche receives FDA approval for the VENTANA MET (SP44) RxDx Assay as the first companion diagnostic to identify non-squamous non-small cell lung cancer patients eligible for treatment with Emrelis
smartShift14.5.2025 21:55:23 CEST | Press release
smartShift Revolutionizes SAP Modernization with AI-Powered Revert to Standard
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom